Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 4/20 | 0.67 |
| ▸ | CA2 | P00918 | 2/20 | 0.67 |
| ▸ | CTSB | P07858 | 2/20 | 0.67 |
| ▸ | CA1 | P00915 | 2/20 | 0.67 |
| ▸ | CTSS | P25774 | 1/20 | 0.67 |
| ▸ | CTSK | P43235 | 1/20 | 0.67 |
| ▸ | GRN | P28799 | 4/20 | 0.65 |
| ▸ | SORT1 | Q99523 | 4/20 | 0.65 |
| ▸ | CA12 | O43570 | 1/20 | 0.58 |
| ▸ | CA9 | Q16790 | 1/20 | 0.58 |
| ▸ | MME | P08473 | 1/20 | 0.56 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | PSMB5 | P28074 | 2/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2158900 | 1.00 | CTSL (0.67) | CTSLCA2CTSBCA1CTSS | |
| SCHEMBL4465251 | 1.00 | CTSL (0.67) | CTSLCA2CTSBCA1CTSS | |
| SCHEMBL20277660 | 0.88 | CTSL (0.65) | CTSLCA2CTSBCA1CTSS | |
| SCHEMBL1640054 | 0.88 | NAALAD2 (0.58) | CTSLCA2CTSBCA1CTSS | |
| SCHEMBL9830474 | 0.87 | PSMB5 (0.72) | CTSLCTSBCTSSCTSKMME | |
| SCHEMBL9830466 | 0.87 | PSMB5 (0.72) | CTSLCTSBCTSSCTSKMME | |
| SCHEMBL4160513 | 0.87 | CA2 (0.68) | CTSLCA2CTSBCA1CTSS | |
| SCHEMBL31611853 | 0.87 | CA2 (0.68) | CTSLCA2CTSBCA1CTSS | |
| SCHEMBL17822178 | 0.87 | HPGDS (0.65) | CTSLCA2CTSBCA1CTSS | |
| SCHEMBL7432512 | 0.87 | CTSL (0.63) | CTSLCA2CTSBCA1CTSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 171 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105749890-A | Chiral stationary phase prepared by taking cinchonidine-boc-amide as chiral selector as well as preparation method and application thereof | 河南科技学院 | 2016-07-13 | — | — | CN | claimed |
| CN-105642261-A | Chiral stationary phase prepared with cinchonine-Boc-amide as chiral selector and preparation method and application thereof | 河南科技学院 | 2016-06-08 | — | — | CN | claimed |
| CN-105561959-A | Chiral stationary phase prepared by taking quinine-tertiary butyl carbamate as a chiral selector and preparation method and application of chiral stationary phase | HENAN INST OF SCIENCE & TECH | 2016-05-11 | — | — | CN | claimed |
| CN-105498736-A | Chiral stationary phase prepared by taking quinindium-t-butyl carbamate as chirality selector as well as preparation method and application of chiral stationary phase | HENAN INST OF SCIENCE & TECH | 2016-04-20 | — | — | CN | claimed |
| CN-101027092-A | Non-absorbent and absorbent articles for inhibiting the production of exoproteins | KIMBERLY CLARK CO (US) | 2007-08-29 | — | — | CN | claimed |
| EP-1793871-A2 | NON-ABSORBENT AND ABSORBENT ARTICLES FOR INHIBITING THE PRODUCTION OF EXOPROTEINS | Kimberly-Clark Worldwide, Inc. (US) | 2007-06-13 | — | — | EP | claimed |
| WO-2006038980-A2 | NON-ABSORBENT AND ABSORBENT ARTICLES FOR INHIBITING THE PRODUCTION OF EXOPROTEINS | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2006-04-13 | — | — | WO | claimed |
| US-20060067991-A1 | Non-absorbent articles for inhibiting the production of exoproteins | KIMBERLY-CLARK WORLDWIDE, INC. | 2006-03-30 | — | — | US | claimed |
| US-20050090652-A1 | Highly homogenous serum albumin as chiral selector | NOVOZYMES DELTA LIMITED (GB) | 2005-04-28 | — | — | US | claimed |
| EP-1465847-A1 | HIGHLY HOMOGENEOUS SERUM ALBUMIN AS CHIRAL SELECTOR | Delta Biotechnology Limited (GB) | 2004-10-13 | — | — | EP | claimed |
| US-20020001591-A1 | Compositions for the delivery of antigens | EMISPHERE TECHNOLOGIES, INC. | 2002-01-03 | — | — | US | claimed |
| US-5958457-A | MIXTURES OF ANTIGENS WITH ADJUVANTS AND ACYLATED AMINO ACIDS OR SALTS, POLYMERS OR SULFONATED AMINO ACIDS | EMISPHERE TECHNOLOGIES, INC. (US) | 1999-09-28 | — | — | US | claimed |
| EP-0784469-A4 | COMPOSITIONS FOR THE DELIVERY OF ANTIGENS | EMISPHERE TECH INC (US) | 1999-03-24 | — | — | EP | claimed |
| CN-1036832-C | Composition containing a penem or carbapenem artibiotic and the use of the same | SANKYO CO (JP) | 1997-12-31 | — | — | CN | claimed |
| EP-0784469-A1 | COMPOSITIONS FOR THE DELIVERY OF ANTIGENS | Emisphere Technologies, Inc. (US) | 1997-07-23 | — | — | EP | claimed |
| WO-1996012474-A1 | COMPOSITIONS FOR THE DELIVERY OF ANTIGENS | EMISPHERE TECHNOLOGIES, INC. (US) | 1996-05-02 | — | — | WO | claimed |
| EP-0226304-B1 | COMPOSITION CONTAINING A PENEM OR CARBAPENEM ANTIBIOTIC | SANKYO COMPANY LIMITED (JP) | 1991-08-28 | — | — | EP | claimed |
| US-4757066-A | Reduces renal toxicity | SANKYO COMPANY LIMITED (JP) | 1988-07-12 | — | — | US | claimed |
| EP-0226304-A1 | Composition containing a penem or carbapenem antibiotic | SANKYO COMPANY LIMITED (JP) | 1987-06-24 | — | — | EP | claimed |
| CN-86107574-A | Compositions containing penem or carbapenem antibiotics and their use | — | 1987-05-20 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020001591-A1 | Compositions for the delivery of antigens | CD47, CD74, LY96 | CTSL 1932/4885CA2 455/4885CTSB 1265/4885 |
| US-20060067991-A1 | Non-absorbent articles for inhibiting the production of exoproteins | SLC43A1, MRPL21, SLC7A5 | CTSL 2689/4885CA2 1875/4885CTSB 3154/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.